Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade

This commentary summarizes current knowledge on the clinical presentation, management, and outcomes of the inflammatory arthritis which may occur as an immune‐related adverse evet of immune checkpoint inhibitor therapy. Herein, we propose a new algorithm aimed at assisting oncologists in the diagnos...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Naidoo, Jarushka, Cappelli, Laura C., Forde, Patrick M., Marrone, Kristen A., Lipson, Evan J., Hammers, Hans J., Sharfman, William H., Le, Dung T., Baer, Alan N., Shah, Ami A., Albayda, Jemima, Manno, Rebecca L., Haque, Uzma, Gutierrez, Anna Kristina, Bingham, Clifton O., Brahmer, Julie R.
Formato: Artigo
Idioma:Inglês
Publicado: AlphaMed Press 2017
Assuntos:
Commentary
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5469592/
https://ncbi.nlm.nih.gov/pubmed/28576858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0390
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares